Shaf Keshavjee

Shaf Keshavjee

Dr.

ON, CANADA
We have developed a technique of lung preservation (LPD solution) that has lead to significant improvements in lung function after transplant. A major project is gene therapy in lung transplantation.

Dr. Shaf Keshavjee is a Thoracic surgeon and Director of the Toronto Lung Transplant Program. He is Surgeon-in-Chief, James Wallace McCutcheon Chair in Surgery at University Health Network in Toronto, and Professor Division of Thoracic Surgery and Institute of Biomaterials and Biomedical Engineering at the University of Toronto.

Dr. Keshavjee completed his medical training at the University of Toronto in 1985. He subsequently trained in General Surgery, Cardiac Surgery and Thoracic Surgery at the University of Toronto followed by fellowship training at Harvard University and the University of London for airway surgery and heart-lung transplantation respectively. He joined the faculty at the University of Toronto in 1994 and was promoted to full professor in 2002. Dr. Keshavjee served as the Chair of the Division of Thoracic Surgery at the University of Toronto from 2004 to 2010. He was also the inaugural holder of the Pearson-Ginsberg Chair in Thoracic Surgery.

Dr. Keshavjee's clinical practice is in thoracic oncology, lung cancer and lung transplantation. He has a passion for surgery and innovative research. He is a scientist in the McEwen Center for Regenerative Medicine at UHN. He leads a team of researchers in a leading research program and is widely published in the field. His specific research interest is in lung injury related to transplantation. His current work involves the study of molecular diagnostics and gene therapy strategies to repair organs and to engineer superior organs for transplantation.

Dr. Keshavjee has served on the board of directors of the International Society for Heart and Lung Transplantation, The Canadian Society of Transplantation and on the Governing Council of the American Association for Thoracic Surgery. He has received numerous awards for contributions to his field, including the George Armstrong Peters Young Investigator Award, Canada's Top 40 Under 40 Award, the Colin Woolf Award for Excellence in Medical Education and the Lister Prize in Surgery - the highest award for research achievement in the Department of Surgery. He is a Fellow of the Canadian Academy of Health Sciences and has been awarded an Honorary Doctor of Science Degree from Ryerson University, as well as an Honorary Doctorate of Science from Queen's University. He has also received two Queen Elizabeth II Diamond Jubilee Medals and the Order of Ontario.

Dr. Shaf Keshavjee is a Thoracic surgeon and Director of the Toronto Lung Transplant Program. He is Surgeon-in-Chief, James Wallace McCutcheon Chair in Surgery at University Health Network in Toronto, and Professor Division of Thoracic Surgery and Institute of Biomaterials and Biomedical Engineering at the University of Toronto.

Dr. Keshavjee completed his medical training at the University of Toronto in 1985. He subsequently trained in General Surgery, Cardiac Surgery and Thoracic Surgery at the University of Toronto followed by fellowship training at Harvard University and the University of London for airway surgery and heart-lung transplantation respectively. He joined the faculty at the University of Toronto in 1994 and was promoted to full professor in 2002. Dr. Keshavjee served as the Chair of the Division of Thoracic Surgery at the University of Toronto from 2004 to 2010. He was also the inaugural holder of the Pearson-Ginsberg Chair in Thoracic Surgery.

Dr. Keshavjee's clinical practice is in thoracic oncology, lung cancer and lung transplantation. He has a passion for surgery and innovative research. He is a scientist in the McEwen Center for Regenerative Medicine at UHN. He leads a team of researchers in a leading research program and is widely published in the field. His specific research interest is in lung injury related to transplantation. His current work involves the study of molecular diagnostics and gene therapy strategies to repair organs and to engineer superior organs for transplantation.

Dr. Keshavjee has served on the board of directors of the International Society for Heart and Lung Transplantation, The Canadian Society of Transplantation and on the Governing Council of the American Association for Thoracic Surgery. He has received numerous awards for contributions to his field, including the George Armstrong Peters Young Investigator Award, Canada's Top 40 Under 40 Award, the Colin Woolf Award for Excellence in Medical Education and the Lister Prize in Surgery - the highest award for research achievement in the Department of Surgery. He is a Fellow of the Canadian Academy of Health Sciences and has been awarded an Honorary Doctor of Science Degree from Ryerson University, as well as an Honorary Doctorate of Science from Queen's University. He has also received two Queen Elizabeth II Diamond Jubilee Medals and the Order of Ontario.

Lung Transplantation

Lung Transplantation

Educational / InformativeTechnical / Specific

Clinical Research

Clinical Research

Educational / InformativeTechnical / Specific

Medical Research

Medical Research

Educational / InformativeTechnical / Specific

Molecular Diagnostics

Molecular Diagnostics

Educational / InformativeTechnical / Specific

Gene Therapy

Gene Therapy

Educational / InformativeTechnical / Specific

Surgical Leadership

Surgical Leadership

Educational / InformativeTechnical / Specific

Thoracic Surgery

Thoracic Surgery

Educational / InformativeTechnical / Specific

Ex-Vivo Process For Transplant

Ex-Vivo Process For Transplant

Educational / InformativeTechnical / Specific

Surgery And Critical Care

Surgery And Critical Care

Educational / InformativeTechnical / Specific

Multi-Organ Transplan

Multi-Organ Transplan

Educational / InformativeTechnical / Specific